Overcoming Limitations and Barriers Associated with Treating Pulmonary Arterial Hypertension
An expert on pulmonary arterial hypertension discusses the limitations of current therapies and the barriers to early diagnosis.
Source: ajmc.com
Stay updated with breaking news from Barriers Associated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An expert on pulmonary arterial hypertension discusses the limitations of current therapies and the barriers to early diagnosis.
Cornell Prime Dots, also called C’Dots, are ultrasmall fluorescent core-shell hybrid silica nanoparticles that have been thought to only be effective when administered intravenously. However, recent studies have demonstrated the possibility of administering them orally.